[go: up one dir, main page]

GR3032238T3 - Heteroaryl cycloalkenyl hydroxyureas - Google Patents

Heteroaryl cycloalkenyl hydroxyureas

Info

Publication number
GR3032238T3
GR3032238T3 GR990403325T GR990403325T GR3032238T3 GR 3032238 T3 GR3032238 T3 GR 3032238T3 GR 990403325 T GR990403325 T GR 990403325T GR 990403325 T GR990403325 T GR 990403325T GR 3032238 T3 GR3032238 T3 GR 3032238T3
Authority
GR
Greece
Prior art keywords
alkyl
hydrogen
pct
fluoro
chloro
Prior art date
Application number
GR990403325T
Other languages
English (en)
Inventor
Akiyoshi Kawai
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR3032238T3 publication Critical patent/GR3032238T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
GR990403325T 1993-07-20 1999-12-22 Heteroaryl cycloalkenyl hydroxyureas GR3032238T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17940193 1993-07-20
PCT/JP1994/001093 WO1995003292A1 (en) 1993-07-20 1994-07-05 Heteroaryl cycloalkenyl hydroxyureas

Publications (1)

Publication Number Publication Date
GR3032238T3 true GR3032238T3 (en) 2000-04-27

Family

ID=16065226

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403325T GR3032238T3 (en) 1993-07-20 1999-12-22 Heteroaryl cycloalkenyl hydroxyureas

Country Status (11)

Country Link
US (1) US5665768A (el)
EP (1) EP0710233B1 (el)
JP (1) JPH08511029A (el)
AT (1) ATE185563T1 (el)
CA (1) CA2167715C (el)
DE (1) DE69421183T2 (el)
DK (1) DK0710233T3 (el)
ES (1) ES2139746T3 (el)
FI (1) FI943420A7 (el)
GR (1) GR3032238T3 (el)
WO (1) WO1995003292A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016054A1 (en) * 1994-11-18 1996-05-30 Pfizer Pharmaceuticals Inc. Cycloalkenyl-n-hydroxyureas
EP1235598A2 (en) * 1999-11-12 2002-09-04 Angiotech Pharmaceuticals, Inc. Compositions of a combination of radioactive therapy and cell-cycle inhibitors
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
ATE515277T1 (de) 2002-05-24 2011-07-15 Angiotech Int Ag Zusammensetzungen und verfahren zum beschichten von medizinischen implantaten
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334975C (en) * 1987-11-13 1995-03-28 James H. Holms Furan and pyrrole containing lipoxygenase inhibiting compounds
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物
JPH0717612B2 (ja) * 1991-06-28 1995-03-01 ファイザー製薬株式会社 新規なテトラヒドロベンズアゼピン誘導体
JP2989951B2 (ja) * 1991-10-25 1999-12-13 ファイザー製薬株式会社 新規なシクロアルキル尿素誘導体および組成物
US5521212A (en) * 1991-12-13 1996-05-28 Pfizer Inc. Cyclopropyl N-hydroxyurea and N-hydroxyacetamides which inhibit lipoxygenase
US5169854A (en) * 1992-02-26 1992-12-08 Abbott Laboratories N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity
US5187192A (en) * 1992-03-13 1993-02-16 Abbott Laboratories Cyclobutyl derivatives having lipoxygenase inhibitory activity

Also Published As

Publication number Publication date
FI943420L (fi) 1995-01-21
FI943420A0 (fi) 1994-07-19
EP0710233B1 (en) 1999-10-13
FI943420A7 (fi) 1995-01-21
JPH08511029A (ja) 1996-11-19
DE69421183T2 (de) 2000-01-20
EP0710233A1 (en) 1996-05-08
ES2139746T3 (es) 2000-02-16
DE69421183D1 (de) 1999-11-18
CA2167715C (en) 1998-10-06
ATE185563T1 (de) 1999-10-15
DK0710233T3 (da) 2000-01-03
US5665768A (en) 1997-09-09
CA2167715A1 (en) 1995-02-02
WO1995003292A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
NO972261L (no) Hypolipidemiske benzodiazepiner
MY121606A (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor and pharmaceutical compositions comprising them
FI955012A0 (fi) Herbisidiset (4-substituoitu pyridyyli)-3-karbinolit
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
WO2003024953A1 (en) Propanolamine derivative having 1,4-benzodioxane ring
GR3032238T3 (en) Heteroaryl cycloalkenyl hydroxyureas
AR005120A1 (es) Derivados 4-(1h-benzimidazol-2-il) [1,4]diazepanos substituidos utiles para el tratamiento de enfermedades alergicas, composicion farmaceutica y usos en la fabricacion de medicamentos.
NO995594D0 (no) Nye substituerte heterocykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
MY134478A (en) Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives
ATE167180T1 (de) Cycloalkylhydroxyharnstoffe und ihre verwendung als lipoxy-genase-inhibitoren
CA2169066A1 (en) Phenoxyphenyl Cyclopentenyl Hydroxyureas
HU9401762D0 (en) Imidazole lipoxygenase inhibitors
IE902213L (en) Microbiocidal compositions
EP0806204A4 (en) Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient
IL111774A (en) Pharmaceutical compositions containing heterocyclic benzenesulfonylimine derivatives and some such novel compounds
EP0773219A4 (en) IMIDAZOQUINOLEIN DERIVATIVE
JO1674B1 (en) Benzimidazole is an alternative and method of preparation and use of a pharmacist